Evidence map›Paper›PMID 35773094›Full record

ArticleLa Revue de medecine interne2022

Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France.

L Dufayet, W Caré, H Laborde-Casterot, L Chouachi, J Langrand, D Vodovar

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in La Revue de medecine interne, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

L DufayetCentre antipoison de Paris - Fédération de toxicologie (FeTox), hôpital Fernand-Widal, AP-HP, 75010 Paris, France; Inserm, UMRS-1144, Faculté de pharmacie, 75006 Paris, France; Unité Médico-judiciaire, Hôtel-Dieu, AP-HP, 75001 Paris, France; UFR de médecine, université de Paris, 75010 Paris, France.
W CaréCentre antipoison de Paris - Fédération de toxicologie (FeTox), hôpital Fernand-Widal, AP-HP, 75010 Paris, France; Service de médecine interne, hôpital d'instruction des armées Bégin, 94160 Saint-Mandé, France.
H Laborde-CasterotCentre antipoison de Paris - Fédération de toxicologie (FeTox), hôpital Fernand-Widal, AP-HP, 75010 Paris, France.
L ChouachiCentre d'addictovigilance de Paris, hôpital Fernand Widal, AP-HP, Paris, France.
J LangrandCentre antipoison de Paris - Fédération de toxicologie (FeTox), hôpital Fernand-Widal, AP-HP, 75010 Paris, France.
D VodovarCentre antipoison de Paris - Fédération de toxicologie (FeTox), hôpital Fernand-Widal, AP-HP, 75010 Paris, France; Inserm, UMRS-1144, Faculté de pharmacie, 75006 Paris, France; UFR de médecine, université de Paris, 75010 Paris, France. Electronic address: dominique.vodovar@aphp.fr.
Université Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRecreational use of nitrous oxide (N

methodsWe retrospectively analyzed N

resultsDuring the study period, 93 cases of N

conclusionDespite a marked increase in recreational N

Indexed as

COVID-19Substance-Related DisordersAdultCommunicable Disease ControlFemaleFranceHumansMaleNitrous OxidePandemicsParisRetrospective StudiesYoung AdultNitrous Oxideabus de droguesCOVID-19Drug MisuseNitrous OxideProtoxyde d’azote

Identifiers

PMID35773094
PMCPMC9371623
OpenAlexW4282976729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.